Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis

A new coronavirus associated with human respiratory disease in China

(2020) Fan Wu et al.   NATURE

COVID-19 and its implications for thrombosis and anticoagulation

(2020) Jean Marie Connors et al.   BLOOD

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

(2020) Evangelos J. Giamarellos-Bourboulis et al.   Cell Host & Microbe

Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?

(2020) Courtney M. Campbell et al.   CIRCULATION

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

(2020) Chuan Qin et al.   CLINICAL INFECTIOUS DISEASES

Alterations of B Cells in Immunosuppressive Phase of Septic Shock Patients*

(2020) Xijie Dong et al.   CRITICAL CARE MEDICINE

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

(2020) Waleed Alhazzani et al.   INTENSIVE CARE MEDICINE

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

(2020) Chi Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

SARS-CoV-2: a storm is raging

(2020) Savannah F. Pedersen et al.   JOURNAL OF CLINICAL INVESTIGATION

The case of Complement activation in COVID-19 multiorgan impact

(2020) Marina Noris et al.   KIDNEY INTERNATIONAL

SARS-CoV-2 and viral sepsis: observations and hypotheses

(2020) Hui Li et al.   LANCET

Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis

(2020) Huan Li et al.   LEUKEMIA

Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA

(2020) Marion Ferreira et al.   Annals of Intensive Care

Immunotherapies for COVID-19: lessons learned from sepsis

(2020) Kenneth E Remy et al.   Lancet Respiratory Medicine

Novel coronavirus in a 15-day-old neonate with clinical signs of sepsis, a case report

(2020) Mojtaba Kamali Aghdam et al.   Infectious Diseases

Rationale for targeting complement in COVID‐19

(2020) Anastasia Polycarpou et al.   EMBO Molecular Medicine

COVID-19, microangiopathy, hemostatic activation, and complement

(2020) Wen-Chao Song et al.   JOURNAL OF CLINICAL INVESTIGATION

COVID-19: Complement, Coagulation, and Collateral Damage

(2020) Martin W. Lo et al.   JOURNAL OF IMMUNOLOGY

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Is a “Cytokine Storm” Relevant to COVID-19?

(2020) Pratik Sinha et al.   JAMA Internal Medicine

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

(2020) Yujun Tang et al.   Frontiers in Immunology

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

(2020) Jia Yu et al.   BLOOD

Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions

(2020) Matthijs Kox et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence

(2020) Khan Sharun et al.   International Journal of Surgery

Sepsis roadmap: What we know, what we learned, and where we are going

(2019) Vijay Kumar   CLINICAL IMMUNOLOGY

Role of complement C5a and histones in septic cardiomyopathy

(2018) Fatemeh Fattahi et al.   MOLECULAR IMMUNOLOGY

Janus face of complement-driven neutrophil activation during sepsis

(2018) R. Halbgebauer et al.   SEMINARS IN IMMUNOLOGY

Lactate and Immunosuppression in Sepsis

(2018) Benjamin Nolt et al.   SHOCK

Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation

(2018) Scott J. Denstaedt et al.   Frontiers in Immunology

Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia

(2018) Marwan Bouras et al.   Frontiers in Immunology

Cytokine storm and sepsis disease pathogenesis

(2017) Benjamin G. Chousterman et al.   Seminars in Immunopathology

Autophagy: A Potential Therapeutic Target for Reversing Sepsis-Induced Immunosuppression

(2017) Chao Ren et al.   Frontiers in Immunology

Apoptosis-induced lymphopenia in sepsis and other severe injuries

(2016) Thibaut Girardot et al.   APOPTOSIS

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Reduced Immunocompetent B Cells and Increased Secondary Infection in Elderly Patients With Severe Sepsis

(2016) Kodai Suzuki et al.   SHOCK

Genipin attenuates sepsis-induced immunosuppression through inhibition of T lymphocyte apoptosis

(2015) Joon-Sung Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Persistent Lymphopenia After Diagnosis of Sepsis Predicts Mortality

(2014) Anne M. Drewry et al.   SHOCK

Why have clinical trials in sepsis failed?

(2014) John C. Marshall   TRENDS IN MOLECULAR MEDICINE

Failure of treatments based on the cytokine storm theory of sepsis: time for a novel approach

(2013) Evangelos J Giamarellos-Bourboulis   Immunotherapy

Innate Response Activator B Cells Protect Against Microbial Sepsis

(2012) P. J. Rauch et al.   SCIENCE

Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure

(2011) Jonathan S. Boomer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

EARLY ASSESSMENT OF LEUKOCYTE ALTERATIONS AT DIAGNOSIS OF SEPTIC SHOCK

(2010) Fabienne Venet et al.   SHOCK

Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival

(2009) M. Lamkanfi et al.   BLOOD